"No junk science": EFPIA's "3D" approach to data sharing
This article was originally published in Scrip
Executive Summary
Europe's pharmaceutical industry body EFPIA has again set out its views on just how much clinical trial data should be shared with researchers and the public, this time in a blog entitled "A 3D view of responsible clinical data sharing" that insists on safeguards to protect against "junk science".